genedrive plc is focused on decentralising molecular diagnostics, concentrating on applications where our technology will provide sustainable growth
Diagnostics: Rapid and accurate diagnosis of infectious disease facilitating immediate therapeutic treatment.
Pharmacogenomics: Allowing medicine to be personalised around an individual patient's genotype.
Future applications: Genedrive® is being validated for use in the areas of pathogen detection & biosurveillance and aquaculture.
genedrive plc at a glance >
Share price details >
View all regulatory news >
30 March 2021
Interim Report and Accounts 31 December 2020
View all reports >
Tuesday August 31, 2021
genedrive readies system for antibiotic-induced hearing loss launch
Thursday July 01, 2021
Proactive headlines: KR1, Shanta Gold, Cloudbreak Discovery…
Wednesday February 03, 2021
Genedrive close to hitting the market with coronavirus tests
View all news >
On the 8th June 2018 Genedrive Plc disposed of the business and assets of Epistem Ltd. Please follow this link to be redirected to the website of Epistem Ltd
© 2017-21 genedrive plc
Don't show this again